Abstract:Background: Many infectious diseases that cause significant morbidity and mortality, especially in the developing world, could be preventable through vaccination. The effort to produce safe, thermally stable, and needle-free mucosal vaccines has become increasingly important for global health considerations. We have previously demonstrated that a thermally stable nanoemulsion, a mucosal adjuvant for needle-free nasal immunization, is safe and induces protective immunity with a variety of antigens, including recombinant protein. The successful use of nanoemulsion-based vaccines, however, poses numerous challenges. Among the challenges is optimization of the formulation to maintain thermal stability and potency and another is accuracy and efficiency of dispensing the vaccines to the nasal mucosa in the anterior and turbinate region of the nasal cavity or potentially to the nasopharynx-associated lymphoid tissue. Methods: We have examined the effects of different diluents [phosphate-buffered saline (PBS) and 0.9% NaCl] on the stability and potency of nanoemulsion-based vaccines. In addition, we have determined the efficiency of delivering them using commercially available nasal spray devices (Pfeiffer SAP-62602 multidose pump and the BD Hypak SCF 0.5 ml unit dose Accuspray(TM)). Results: We report the stability and potency of PBS-diluted ovalbumin-nanomeulsion mixtures for up to 8 months and NaCl-diluted mixtures up to 6 months when stored at room temperature. Significant differences in spray characteristics including droplet size, spray angle, plume width, and ovality ratios were observed between the two pumps. Further, we have demonstrated that the nanoemulsion-based vaccines are not physically or chemically altered and retain potency following actuation with nasal spray devices. Using either device, the measured spray characteristics suggest deposition of nanoemulsion-based vaccines in inductive tissues located in the anterior region of the nasal cavity. Conclusions: The results of this study suggest that nanoemulsion-based vaccines do not require specially engineered delivery devices and support their potential use as nasopharyngeal vaccine adjuvants.

Preparation of Oral Vaccine Microspheres for Newcastle Disease Virus

Preparation And Efficacy Of Newcastle Disease Virus Dna Vaccine Encapsulated In Plga Nanoparticles

Development of PLGA-PEG-PLGA Hydrogel Delivery System for Enhanced Immunoreaction and Efficacy of Newcastle Disease Virus DNA Vaccine

Self-encapsulating Poly(lactic-co-glycolic acid) (PLGA) Microspheres for Intranasal Vaccine Delivery

Process Optimization of Scaled-Up Production and Biosafety Evaluation of the Dimethyl-Dioctadecyl-Ammonium Bromide/Poly(lactic acid) Nano-Vaccine

Preparation and in Vitro Study of Hydrochloric Norvancomycin Encapsulated Poly (D,l-Lactide-co-glycolide, PLGA) Microspheres for Potential Use in Osteomyelitis

Preparation of the inactivated Newcastle disease vaccine by plasma activated water and evaluation of its protection efficacy

[Preparation, Release and Immunogenicity Evaluation of HBsAg-PLGA Microspheres].

Study on Preparative Conditions for Polylactide Microspheres Containing Tetanus Toxoid

Authorizing of Immunogenicity of Concentrated and Purified Newcastle Disease Virus V4 Strain using Downstream Processing

Efficacy of chitosan nanoparticles as adjuvant in development of an inactivated Newcastle Disease Virus(genotype VII) vaccine.

A comparative study of using Poly (D, L, lactide-co-Glycolic Acid) and Chitosan nanoparticle as vaccine delivery system for a recombinant fusion protein of Newcastle disease virus

Intranasally Delivered Adenoviral Vector Protects Chickens against Newcastle Disease Virus: Vaccine Manufacturing and Stability Assessments for Liquid and Lyophilized Formulations

Drug-nanoencapsulated PLGA Microspheres Prepared by Emulsion Electrospray with Controlled Release Behavior

Thermostable vacuum foam dried Newcastle disease vaccine: Process optimization and pilot-scale study

Exploration of the Delivery of Oncolytic Newcastle Disease Virus by Gelatin Methacryloyl Microneedles

Nano and Microparticles as Potential Oral Vaccine Carriers and Adjuvants Against Infectious Diseases

Spray Drying of Bacterial Membrane Vesicles for Vaccine Delivery

Intranasal immunization with O-2'-Hydroxypropyl trimethyl ammonium chloride chitosan nanoparticles loaded with Newcastle disease virus DNA vaccine enhances mucosal immune response in chickens

Characterization of stability and nasal delivery systems for immunization with nanoemulsion-based vaccines

Efficient oral vaccination by bioengineering virus-like particles with protozoan surface proteins